Effects of Zhaoyangwan on chronic hepatitis B and posthepatic cirrhosis

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:Luke_ibox
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To study the therapeutic effects of zhaoyangwan(ZYW) on chronic hepatitis B and hepatic cirrhosis and the anti-virus, anti-fibrosis and immunoregulatory mechanisms of ZYW.METHODS: Fiftycases of chronic hepatitis B and posthepatic cirrhosis with positive serum HBsAg, HBeAg, anti-Hbc and HBV-DNA were divided randomly and single-blindly into the treatment group (treated with ZYW) and the control group (treated with interferon). After 3 month treatment,the effects of the treatment group and the control group were evaluated.RESULTS: The serum ALT normalization was 83.3%(30/36) in the treatment group and 85.7%(12/14) in the control group, with no significant difference (X2=0.043, P>0.05).After the course, the negative expression rates of the serum HBV-DNA and HBeAg were 44.4%(16/36) and 50%(18/36)in the treatment group, and 50%(7/14) and 50%(7/14) in the control group, respectively, with no significant difference(X2=0.125, X2=0.00, both P>0.05). Negative HBsAg and positive HBsAb appeared in 4 cases of the treatment group and 1 case of the control group. Serum anti-HBc ted negative in 6 cases of the treatment group and 1 case of the control group, respectively. After the ZYW treatment,serum CD3+, CD4+, CD8+, CD4+/CD8+ and NK cell activation were significantly increased. Only serum CD3+ and NK cell activation were significantly increased in the control group with a significant difference between the two groups. The serum C4, C1q, C3, B and C9 were significantly increased in the treatment group. In the control group only the serum C4 was increased. The concentration of serum interferon had no change after treatment with ZYW, while it was significantly increased in the control group after treatment with interferon.The ultrastructure of the liver restored, which helped effectivelyto reduce the degeneration and necrosis of hepatic cells,infiltration of inflammatory cells and hepatic cirrhosis.CONCLUSION: ZYW is a pure Chinese herbal medicine. It can exert potent therapeutic effects on chronic hepatitis Band posthepatic cirrhosis. ZYW has similar therapeutic effects to those of interferon. It is cheap and easily administered with no obvious side-effects. It can be widely used in clinical practice.
其他文献
目的:分析优质护理服务在女性泌尿系统疾病围手术期中应用研究.方法:选择2017年3月到2018年3月在我院接受泌尿系统疾病手术的患者80例作为研究对象.将患者按照随机数字法分为
期刊
目的:探讨通痹汤联合非甾体抗炎药对强直性脊柱炎患者的临床疗效。方法:选取50例强直性脊柱炎患者,随机分为对照组和实验组各25例。对照组患者给予非甾体抗炎药治疗,实验组患者
目的 分析经尿道前列腺等离子电切术治疗高危前列腺增生症的效果.方法 本次研究对象选取我院的高危前列腺增生症患者100例,收治时间为2016年12月到2018年3月,按照接受治疗方
目的:探讨层次理论在男性支气管炎患者护理中的应用效果.方法:选取2017年1月~2018年于我院进行治疗的180例慢性支气管炎患者,随机均分为两组,一组为对照组,一组为实验组.对照
目的 研究新型非肽类肾素抑制剂阿利吉仑对高血压患者缓激肽(BK)和高敏C反应蛋白(hs-CRP)的影响.方法 选取门诊进行治疗的轻、中度原发性高血压患者80例.按随机数字表法分为雷米普利组、阿利吉仑75 mg/d组、阿利吉仑150 mg/d组、阿利吉仑300 mg/d组,每组20例,分别接受雷米普利5 mg/d,阿利吉仑75、150及300 mg/d治疗.采用酶联免疫吸附试验法检测hs-CRP水平
目的 探讨根据骨盆的形态特点选择不同的内固定手术治疗不稳定型骨盆骨折的临床应用价值。方法65例不稳定型骨盆骨折,31例Tile B型骨折经前入路,将耻骨联合或耻骨支复位用重建
目的:探究分析在老年病人护理中应用老年衰弱评估的效果.方法:从2017年4月至2019年4月我院收治的老年患者中抽选148例,采用数字随机分配法将其分为两组,接受常规护理的列为对
期刊
目的 针对妊娠孕妇动态观察胱抑素C的值进而对肾功能受损提出预警.方法 收集2017年1月至2018年5月开始建卡的孕妇共687例(其中正常孕妇592例,妊高症95例),在其12周,24周,36周